Related Topics:
Facility ID: 01432PHRMC25PAT
Facility Name and Address: VERANOVA L.P. 25 PATTON RD DEVENS, MA 01434 Parent Company: AHP-VERANOVA LP Industry: Pharmaceutical Preparation Manufacturing (325412) Chemical: Toluene Reports: View TRI Facility profile report for this facility View TRI Form R submissions by this facility |
|
*You can navigate within the map with your mouse. |
Production Related Waste Management for Selected Chemical
lchemid=0000108883
Chart Options1: |
Waste Management Comparison -
Display facility comparison report for this industry and chemical
Display facility comparison report for this parent company
Pollution Prevention Activities for Selected Chemical
Reporting Year | Section 8.10: Newly Implemented Source Reduction Activity | Section 8.10: Methods to Identify Activity | Section 8.11: Optional Pollution Prevention Information* |
---|---|---|---|
2019 |
Barriers: B3-Barriers to P2 B3 - Concern that product quality may decline as a result of source reduction.
|
Barriers to P2: B3 - Concern that product quality may decline as a result of source reduction. - JM IS A CONTRACT PHARMACEUTICAL MANUFACTURING AND RESEARCH FIRM WHICH MANUFACTURES PRODUCTS ON A BATCH BASIS BY CLIENT. THE CLIENTS PROJECTS DICTATE THE CHEMICALS USED AND THE QUANTITIES. AS THESE PRODUCTS MAY BE IN FDA APPROVAL PROCESS OR ALREADY FDA APPROVED JM HAS LITTLE OPPORTUNITY TO ENCOURAGE LESS HAZARDOUS CHEMICAL SUBSTITUTIONS. WHEN POSSIBLE IN EARLY STAGES OF WORKING WITH NEW CLIENT, JM WILL OFFER TO OPTIMIZE PROCESS WHICHMAY RESULT IN LESS CHEMICALS USED OVERALL BY REDUCING NUMBER OF FILTRATIONS, WASHES, ETC. |
|
2018 |
Barriers: B3-Barriers to P2 B3 - Concern that product quality may decline as a result of source reduction.
|
Barriers to P2: B3 - Concern that product quality may decline as a result of source reduction. - JM IS A CONTRACT PHARMACEUTICAL MANUFACTURING AND RESEARCH FIRM WHICH MANUFACTURES PRODUCTS ON A BATCH BASISBY CLIENT. THE CLIENTS PROJECTS DICTATE THE CHEMICALS USED AND THE QUANTITIES. AS THESE PRODUCTS MAY BE IN FDAAPPROVAL PROCESS OR ALREADY FDA APPROVED JM HAS LITTLE OPPORTUNITY TO ENCOURAGE LESS HAZARDOUS CHEMICALSUBSTITUTIONS. WHEN POSSIBLE IN EARLY STAGES OF WORKING WITH NEW CLIENT, JM WILL OFFER TO OPTIMIZE PROCESS WHICHMAY RESULT IN LESS CHEMICALS USED OVERALL BY REDUCING NUMBER OF FILTRATIONS, WASHES, ETC. |
|
2017 |
Other Barriers to Source Reduction - JM IS A CONTRACT PHARMACEUTICAL MANUFACTURING AND RESEARCH FIRM WHICH MANUFACTURES PRODUCTS ON A BATCH BASIS BY CLIENT. THE CLIENTS PROJECTS DICTATE THE CHEMICALS USED AND THE QUANTITIES. AS THESE PRODUCTS MAY BE IN FDA APPROVAL PROCESS OR ALREADY FDA APPROVED JM HAS LITTLE OPPORTUNITY TO ENCOURAGE LESS HAZARDOUS CHEMICAL SUBSTITUTIONS. WHEN POSSIBLE IN EARLY STAGES OF WORKING WITH NEW CLIENT, JM WILL OFFER TO OPTIMIZE PROCESS WHICH MAY RESULT IN LESS CHEMICALS USED OVERALL BY REDUCING NUMBER OF FILTRATIONS, WASHES, ETC. Other Environmental Practices: Energy Recovery - JM waste vendors seek opportunities to dispose of hazardous waste through energy recovery options whenever possible. |
||
2016 |
Barriers: B3-Barriers to P2 B3 - Concern that product quality may decline as a result of source reduction.
|
Barriers to P2: B3 - Concern that product quality may decline as a result of source reduction. - JM is a pharmaceutical contract manufacturing company which manufactures active pharmaceutical ingredients and intermediates for clients. Chemical usage is dependent upon the clients' project requirements and whether the API or intermediate is in the FDA phase approval process. Once a compound is in the FDA approval process, changes to chemicals are often disapproved by clients. Projects are completed in a batch process model and each client's project may require different chemicals and different amounts of chemicals. |
|
2014 |
Other Barriers to Source Reduction - The batch process and client project needs determine the chemcials used and the amounts. |
||
2013 |
Source Reduction:: W58: Other process modifications
|
Methods to Identify SR Opportunities: T11: Other
|
W58: The operations team will review the processes to determine where there are opportunities to reduce or reuse solvents. Source Reduction - The processes are reviewed to determine if the distillates can be reused to further process materials or if the distillates can be used for cleaning. This reduces the need for virgin solvent. Whether this can be done is contingent upon the processes and if the client permits this activity. |